Literature DB >> 16369839

The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.

Silke Metzger1, Peter Bauer, Juergen Tomiuk, Franco Laccone, Stefano Didonato, Cinzia Gellera, Paola Soliveri, Herwig W Lange, Helga Weirich-Schwaiger, Gregor K Wenning, Bela Melegh, Victoria Havasi, Lazlo Balikó, Stefan Wieczorek, Larissa Arning, Jacek Zaremba, Anna Sulek, Dorota Hoffman-Zacharska, A Nazli Basak, Nagehan Ersoy, Jana Zidovska, Vera Kebrdlova, Massimo Pandolfo, Pascale Ribaï, Ludovit Kadasi, Marta Kvasnicova, Bernhard H F Weber, Friedmar Kreuz, Matthias Dose, Manfred Stuhrmann, Olaf Riess.   

Abstract

An expanded polyglutamine stretch in the huntingtin protein has been identified as the pathogenetic cause of Huntington's disease (HD). Although the length of the expanded polyglutamine repeat is inversely correlated with the age-at-onset, additional genetic factors are thought to modify the variance in the disease onset. As linkage analysis suggested a modifier locus on chromosome 4p, we investigated the functional relevance of S18Y polymorphism of the ubiquitin carboxy-terminal hydrolase L1 in 946 Caucasian HD patients. In this group, the allelic variation on locus S18Y is responsible for 1.1% of the variance in the HD age-at-onset, and the rare Y allele is associated with younger-aged cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16369839     DOI: 10.1007/s10048-005-0023-z

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  10 in total

Review 1.  The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.

Authors:  M G Spillantini; M Goedert
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.

Authors:  Yichin Liu; Lara Fallon; Hilal A Lashuel; Zhihua Liu; Peter T Lansbury
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

3.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.

Authors:  R R Brinkman; M M Mezei; J Theilmann; E Almqvist; M R Hayden
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.

Authors:  D M Maraganore; M J Farrer; J A Hardy; S J Lincoln; S K McDonnell; W A Rocca
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

5.  Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients.

Authors:  P Wintermeyer; R Krüger; W Kuhn; T Müller; D Woitalla; D Berg; G Becker; E Leroy; M Polymeropoulos; K Berger; H Przuntek; L Schöls; J T Epplen; O Riess
Journal:  Neuroreport       Date:  2000-07-14       Impact factor: 1.837

6.  Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease.

Authors:  Peggy Nazé; Isabelle Vuillaume; Alain Destée; Florence Pasquier; Bernard Sablonnière
Journal:  Neurosci Lett       Date:  2002-08-02       Impact factor: 3.046

7.  Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15.

Authors:  O C Stine; N Pleasant; M L Franz; M H Abbott; S E Folstein; C A Ross
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

8.  Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.

Authors:  Luc Djoussé; Beth Knowlton; Michael R Hayden; Elisabeth W Almqvist; Ryan R Brinkman; Christopher A Ross; Russel L Margolis; Adam Rosenblatt; Alexandra Durr; Catherine Dode; Patrick J Morrison; Andrea Novelletto; Marina Frontali; Ronald J A Trent; Elizabeth McCusker; Estrella Gómez-Tortosa; David Mayo Cabrero; Randi Jones; Andrea Zanko; Martha Nance; Ruth K Abramson; Oksana Suchowersky; Jane S Paulsen; Madaline B Harrison; Qiong Yang; L Adrienne Cupples; Jayalakshmi Mysore; James F Gusella; Marcy E MacDonald; Richard H Myers
Journal:  Neurogenetics       Date:  2004-03-17       Impact factor: 2.660

9.  UCHL1 is a Parkinson's disease susceptibility gene.

Authors:  Demetrius M Maraganore; Timothy G Lesnick; Alexis Elbaz; Marie-Christine Chartier-Harlin; Thomas Gasser; Rejko Krüger; Nobutaka Hattori; George D Mellick; Aldo Quattrone; Jun-Ichi Satoh; Tatsushi Toda; Jian Wang; John P A Ioannidis; Mariza de Andrade; Walter A Rocca; Taksushi Toda
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

10.  A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study.

Authors:  Jian-Liang Li; Michael R Hayden; Elisabeth W Almqvist; Ryan R Brinkman; Alexandra Durr; Catherine Dodé; Patrick J Morrison; Oksana Suchowersky; Christopher A Ross; Russell L Margolis; Adam Rosenblatt; Estrella Gómez-Tortosa; David Mayo Cabrero; Andrea Novelletto; Marina Frontali; Martha Nance; Ronald J A Trent; Elizabeth McCusker; Randi Jones; Jane S Paulsen; Madeline Harrison; Andrea Zanko; Ruth K Abramson; Ana L Russ; Beth Knowlton; Luc Djoussé; Jayalakshmi S Mysore; Suzanne Tariot; Michael F Gusella; Vanessa C Wheeler; Larry D Atwood; L Adrienne Cupples; Marie Saint-Hilaire; Jang-Ho J Cha; Steven M Hersch; Walter J Koroshetz; James F Gusella; Marcy E MacDonald; Richard H Myers
Journal:  Am J Hum Genet       Date:  2003-08-01       Impact factor: 11.025

  10 in total
  21 in total

1.  Genetic background modulates behavioral impairments in R6/2 mice and suggests a role for dominant genetic modifiers in Huntington’s disease pathogenesis.

Authors:  Randi-Michelle Cowin; Nghiem Bui; Deanna Graham; Jennie R Green; Lisa A Yuva-Paylor; Andreas Weiss; Richard Paylor
Journal:  Mamm Genome       Date:  2012-06       Impact factor: 2.957

2.  TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease.

Authors:  Ji-Hyun Lee; Jong-Min Lee; Eliana Marisa Ramos; Tammy Gillis; Jayalakshmi S Mysore; Shotaro Kishikawa; Tiffany Hadzi; Audrey E Hendricks; Michael R Hayden; Patrick J Morrison; Martha Nance; Christopher A Ross; Russell L Margolis; Ferdinando Squitieri; Cinzia Gellera; Estrella Gomez-Tortosa; Carmen Ayuso; Oksana Suchowersky; Ronald J Trent; Elizabeth McCusker; Andrea Novelletto; Marina Frontali; Randi Jones; Tetsuo Ashizawa; Samuel Frank; Marie-Helene Saint-Hilaire; Steven M Hersch; Herminia D Rosas; Diane Lucente; Madaline B Harrison; Andrea Zanko; Ruth K Abramson; Karen Marder; Jorge Sequeiros; G Bernhard Landwehrmeyer; Ira Shoulson; Richard H Myers; Marcy E MacDonald; James F Gusella
Journal:  Biochem Biophys Res Commun       Date:  2012-07-03       Impact factor: 3.575

3.  The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington's Disease Patients.

Authors:  Gemma Tell-Marti; Joan Anton Puig-Butille; Pol Gimenez-Xavier; Ariadna Segu-Roig; Miriam Potrony; Celia Badenas; Victoria Alvarez; José M Millán; María José Trujillo-Tiebas; María A Ramos-Arroyo; Montserrat Milà; Susana Puig
Journal:  Mol Neurobiol       Date:  2016-12-06       Impact factor: 5.590

Review 4.  Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects.

Authors:  Sumeet Kumar; Navneesh Yadav; Sanjay Pandey; B K Thelma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 5.  Genetic modifiers of neurological disease.

Authors:  Jennifer A Kearney
Journal:  Curr Opin Genet Dev       Date:  2011-01-19       Impact factor: 5.578

6.  Age at onset in Huntington's disease is modified by the autophagy pathway: implication of the V471A polymorphism in Atg7.

Authors:  Silke Metzger; Meiju Saukko; Hong Van Che; Liang Tong; Yvonne Puder; Olaf Riess; Huu Phuc Nguyen
Journal:  Hum Genet       Date:  2010-08-10       Impact factor: 4.132

7.  Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease.

Authors:  Silke Metzger; Peter Bauer; Jürgen Tomiuk; Franco Laccone; Stefano Didonato; Cinzia Gellera; Caterina Mariotti; Herwig W Lange; Helga Weirich-Schwaiger; Gregor K Wenning; Klaus Seppi; Bela Melegh; Viktoria Havasi; Laszlo Balikó; Stefan Wieczorek; Jacek Zaremba; Dorota Hoffman-Zacharska; Anna Sulek; A Nazli Basak; Esra Soydan; Jana Zidovska; Vera Kebrdlova; Massimo Pandolfo; Pascale Ribaï; Ludovit Kadasi; Marta Kvasnicova; Bernhard H F Weber; Friedmar Kreuz; Matthias Dose; Manfred Stuhrmann; Olaf Riess
Journal:  Hum Genet       Date:  2006-07-18       Impact factor: 4.132

8.  Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset.

Authors:  Meera Swami; Audrey E Hendricks; Tammy Gillis; Tiffany Massood; Jayalakshmi Mysore; Richard H Myers; Vanessa C Wheeler
Journal:  Hum Mol Genet       Date:  2009-05-23       Impact factor: 6.150

9.  Allele-specific silencing of mutant Ataxin-7 in SCA7 patient-derived fibroblasts.

Authors:  Janine Scholefield; Lauren Watson; Danielle Smith; Jacquie Greenberg; Matthew J A Wood
Journal:  Eur J Hum Genet       Date:  2014-03-26       Impact factor: 4.246

10.  Huntington's disease: the case for genetic modifiers.

Authors:  James F Gusella; Marcy E MacDonald
Journal:  Genome Med       Date:  2009-08-21       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.